A Narrative Review of the Safety of Anti-COVID-19 Nutraceuticals for Patients with Cancer
Interest in dietary supplements and their efficacy in treating and preventing disease has increased greatly since the outbreak of the COVID-19 pandemic. Due to the risk of severe COVID-19 in patients with cancer, we conducted a narrative review aiming to better understand the data on the safety of t...
Main Authors: | Karlen Stade Bader-Larsen, Elisabeth Anne Larson, Maria Dalamaga, Faidon Magkos |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-12-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/23/6094 |
Similar Items
-
Diet Supplementation, Probiotics, and Nutraceuticals in SARS-CoV-2 Infection: A Scoping Review
by: Fabio Infusino, et al.
Published: (2020-06-01) -
Nutraceuticals and Herbs in Reducing the Risk and Improving the Treatment of COVID-19 by Targeting SARS-CoV-2
by: Priti Tagde, et al.
Published: (2021-09-01) -
Nutraceuticals in HIV and COVID-19-Related Neurological Complications: Opportunity to Use Extracellular Vesicles as Drug Delivery Modality
by: Sunitha Kodidela, et al.
Published: (2022-01-01) -
Notable Developments for Vitamin D Amid the COVID-19 Pandemic, but Caution Warranted Overall: A Narrative Review
by: Ronan Lordan
Published: (2021-02-01) -
Quercetin as a potential nutraceutic against coronavirus disease 2019 (COVID-19)
by: Júlio César Moreira Brito, et al.
Published: (2021-03-01)